Late-onset and nonlate-onset schizophrenia: A comparison of clinical characteristics in a multicenter study
- PMID: 33580724
- DOI: 10.1002/gps.5512
Late-onset and nonlate-onset schizophrenia: A comparison of clinical characteristics in a multicenter study
Abstract
Objectives: Data are scarce regarding the potential clinical differences between non-late onset schizophrenia (NLOS, i.e., disorder occurring before 40 years of age), late-onset schizophrenia (LOS, occurring between ages 40 and 60 years) and very-late-onset schizophrenia-like psychosis (VLOSLP, occurring after 60 years of age). Furthermore, previous research compared LOS patients with non-age matched NLOS patients. In this study, we sought to examine potential clinical differences between patients of similar age with LOS and NLOS.
Methods/design: This is a cross-sectional multicentre study that recruited in- and outpatients older adults (aged ≥55 years) with an ICD-10 diagnosis of schizophrenia or schizoaffective disorder with NLOS and LOS. Sociodemographic and clinical characteristics, comorbidity, psychotropic medications, quality of life, functioning, and mental health care utilization were drawn for comparison.
Results: Two hundred seventy-two participants (79.8%) had NLOS, 61 (17.9%) LOS, and 8 (2.3%) VLOSLP. LOS was significantly and independently associated with greater severity of emotional withdrawal and lower severity of depression (all p < 0.05). However, the magnitude of these associations was modest, with significant adjusted odds ratios ranging from 0.71 to 1.24, and there were no significant between-group differences in other characteristics.
Conclusion: In an age-matched multicenter sample of elderly patients with schizophrenia, older adults with LOS were largely similar to older adults with NLOS in terms of clinical characteristics. The few differences observed may be at least partially related to symptom fluctuation with time. Implications of these findings for pharmacological and nonpharmacological management is yet to be determined.
Keywords: elderly; late-onset; oldage; schizophrenia.
© 2021 John Wiley & Sons Ltd.
References
-
- Cohen CI, Meesters PD, Zhao J. New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry. 2015;2(4):340-350. https://doi.org/10.1016/S2215-0366(15)00003-6.
-
- Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet Lond Engl. 2013;382(9904):1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6.
-
- Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003;11(6):648-657.
-
- Hoertel N, Limosin F, Leleu H. Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database. Eur Psychiatry J Assoc Eur Psychiatr. 2014;29(6):358-364. https://doi.org/10.1016/j.eurpsy.2013.12.001.
-
- Jeste D, Lanouette N, Vahia I. Schizophrenia and paranoid disorders. In: Blazer DG, Steff ens DC, eds. Textbook of Geriatric Psychiatry. 4th ed. Washington, DC: American Psychiatric Press; 2009:317-331.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
